45,677 Shares in Surgery Partners, Inc. (NASDAQ:SGRY) Purchased by Cubist Systematic Strategies LLC

Cubist Systematic Strategies LLC acquired a new position in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 45,677 shares of the company's stock, valued at approximately $967,000.

Several other institutional investors and hedge funds have also bought and sold shares of the company. American Century Companies Inc. raised its stake in Surgery Partners by 223.9% during the fourth quarter. American Century Companies Inc. now owns 1,399,756 shares of the company's stock worth $29,633,000 after acquiring an additional 967,534 shares in the last quarter. Norges Bank acquired a new position in Surgery Partners during the fourth quarter worth about $15,796,000. Dimensional Fund Advisors LP raised its stake in Surgery Partners by 18.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,577,861 shares of the company's stock worth $75,739,000 after acquiring an additional 563,812 shares in the last quarter. Raymond James Financial Inc. acquired a new position in Surgery Partners during the fourth quarter worth about $10,130,000. Finally, Pentwater Capital Management LP acquired a new position in Surgery Partners during the fourth quarter worth about $8,997,000.

Analysts Set New Price Targets

Several brokerages have commented on SGRY. Royal Bank of Canada reissued an "outperform" rating and set a $35.00 target price on shares of Surgery Partners in a research note on Tuesday, March 25th. Macquarie lowered their price objective on Surgery Partners from $34.00 to $33.00 and set an "outperform" rating for the company in a research note on Tuesday, March 11th. Finally, Benchmark reaffirmed a "buy" rating and issued a $35.00 price objective on shares of Surgery Partners in a research note on Monday, April 21st. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $34.75.

Insider Buying and Selling at Surgery Partners

In other Surgery Partners news, insider Marissa Brittenham sold 3,156 shares of the stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $24.09, for a total transaction of $76,028.04. Following the completion of the sale, the insider now owns 63,408 shares of the company's stock, valued at approximately $1,527,498.72. This represents a 4.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO David T. Doherty sold 6,733 shares of the stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $24.02, for a total value of $161,726.66. Following the transaction, the chief financial officer now owns 150,868 shares in the company, valued at $3,623,849.36. The trade was a 4.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.30% of the company's stock.

Surgery Partners Stock Performance

NASDAQ:SGRY opened at $22.77 on Thursday. The company has a market capitalization of $2.92 billion, a PE ratio of -47.44, a P/E/G ratio of 19.21 and a beta of 1.96. The company has a 50 day simple moving average of $22.55 and a two-hundred day simple moving average of $23.32. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. Surgery Partners, Inc. has a fifty-two week low of $19.50 and a fifty-two week high of $33.97.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its earnings results on Monday, May 12th. The company reported $0.04 earnings per share for the quarter, missing analysts' consensus estimates of $0.08 by ($0.04). The firm had revenue of $776.00 million for the quarter, compared to analyst estimates of $777.77 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The business's revenue for the quarter was up 8.2% compared to the same quarter last year. During the same period in the prior year, the company posted $0.10 EPS. Research analysts anticipate that Surgery Partners, Inc. will post 0.67 earnings per share for the current year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.